NEWS: GlycoBac develops Sf-RVN, a new Sf-rhabdovirus-free S. frugiperda cell line for recombinant protein production

GlycoBac is currently providing Sf-RVN cells to interested parties under commercial Materials Transfer Agreements (for evaluation) and/or licensing agreements (for application) in various fields of use.
Please contact Dr. Jarvis directly for additional information.

Sf-RVN cells are currently the only S. frugiperda cell line that is free of Sf-rhabdovirus contamination - unlike Sf9, Sf21, or Protein Sciences' expresSF+ cell line, which are persistently infected with Sf-rhabdovirus. Learn more about the features of Sf-RVN cells

Read the recent peer-reviewed paper describing Sf-RVN cells published in the Elsevier journal 'Protein expression and purification

Read another peer-reviewed paper published in the Elsevier journal 'Biologicals' about endogenous viral elements discovered by GlycoBac in Sf-RVN and other cell lines


Sf-RVN cells are a safer alternative to commonly used 
S. frugiperda cell lines. Listen to Prof. Dr. Jarvis talk about 
Sf-RVN cells and how they compare to Sf9 cells: